Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications including colorectal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Cancer
• Endometrial Adenocarcinoma
• Gastric Adenocarcinoma
• Ovarian Cancer
• Pancreatic Adenocarcinoma
• Prostate Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• APL-5125

Snippet

Sponsor: Apollo Therapeutics Ltd | Conditions: Colorectal Cancer, Cholangiocarcinoma | Phase 1, Phase 2 | Status: RECRUITING